OPKO Health Shares Outstanding 2010-2024 | OPK

OPKO Health shares outstanding from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
OPKO Health Annual Shares Outstanding
(Millions of Shares)
2023 752
2022 719
2021 648
2020 641
2019 595
2018 563
2017 559
2016 556
2015 488
2014 422
2013 355
2012 296
2011 281
2010 255
2009 233
OPKO Health Quarterly Shares Outstanding
(Millions of Shares)
2024-09-30 998
2024-06-30 697
2024-03-31 707
2023-12-31 752
2023-09-30 752
2023-06-30 752
2023-03-31 752
2022-12-31 719
2022-09-30 750
2022-06-30 713
2022-03-31 660
2021-12-31 648
2021-09-30 652
2021-06-30 647
2021-03-31 641
2020-12-31 641
2020-09-30 641
2020-06-30 641
2020-03-31 641
2019-12-31 595
2019-09-30 586
2019-06-30 586
2019-03-31 586
2018-12-31 563
2018-09-30 560
2018-06-30 560
2018-03-31 559
2017-12-31 559
2017-09-30 559
2017-06-30 564
2017-03-31 558
2016-12-31 556
2016-09-30 552
2016-06-30 557
2016-03-31 546
2015-12-31 488
2015-09-30 516
2015-06-30 462
2015-03-31 446
2014-12-31 422
2014-09-30 428
2014-06-30 413
2014-03-31 413
2013-12-31 355
2013-09-30 361
2013-06-30 337
2013-03-31 313
2012-12-31 296
2012-09-30 298
2012-06-30 298
2012-03-31 298
2011-12-31 281
2011-09-30 286
2011-06-30 285
2011-03-31 261
2010-12-31 255
2010-09-30 255
2010-06-30 255
2010-03-31 254
2009-12-31 233
2009-09-30 253
2009-06-30 226
2009-03-31 200
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.078B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $205.491B 25.07
Intuitive Surgical (ISRG) United States $191.931B 100.35
Alcon (ALC) Switzerland $42.651B 28.54
Edwards Lifesciences (EW) United States $41.817B 26.55
IQVIA Holdings (IQV) United States $37.469B 20.64
IDEXX Laboratories (IDXX) United States $36.904B 43.46
DexCom (DXCM) United States $30.627B 46.12
Waters (WAT) United States $23.276B 34.42
STERIS (STE) Ireland $21.284B 24.50
SONOVA HOLDING (SONVY) Switzerland $20.097B 0.00
Hologic (HOLX) United States $17.200B 18.58
Fresenius Medical Care AG KGaA (FMS) Germany $14.078B 14.45
Sysmex ADR (SSMXY) Japan $13.104B 41.09
Globus Medical (GMED) United States $11.291B 28.59
Penumbra (PEN) United States $9.244B 90.55
Masimo (MASI) United States $9.076B 43.92
Teleflex (TFX) United States $8.687B 13.85
Glaukos (GKOS) United States $7.647B 0.00
PROCEPT BioRobotics (PRCT) United States $4.828B 0.00
Integer Holdings (ITGR) United States $4.639B 26.30
Veracyte (VCYT) United States $3.314B 99.44
Inari Medical (NARI) United States $3.126B 0.00
LivaNova (LIVN) United Kingdom $2.714B 15.67
Nihon Kohden (NHNKY) Japan $2.347B 17.83
TransMedics (TMDX) United States $2.344B 74.30
Elekta AB (EKTAY) Sweden $2.216B 19.92
Tandem Diabetes Care (TNDM) United States $2.108B 0.00
Integra LifeSciences Holdings (IART) United States $1.881B 9.83
RxSight (RXST) United States $1.599B 0.00
Alphatec Holdings (ATEC) United States $1.363B 0.00
Artivion (AORT) United States $1.216B 80.56
Pulse Biosciences (PLSE) United States $1.152B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.852B 14.48
Paragon 28 (FNA) United States $0.837B 0.00
Mesa Laboratories (MLAB) United States $0.712B 16.78
ORTHOFIX MEDICAL INC (OFIX) United States $0.699B 0.00
IRadimed (IRMD) United States $0.693B 37.47
AxoGen (AXGN) United States $0.646B 0.00
Pacific Biosciences Of California (PACB) United States $0.597B 0.00
SiBone (SIBN) United States $0.570B 0.00
OrthoPediatrics (KIDS) United States $0.544B 0.00
Semler Scientific (SMLR) United States $0.515B 30.30
Treace Medical Concepts (TMCI) United States $0.493B 0.00
Tactile Systems Technology (TCMD) United States $0.441B 23.84
ClearPoint Neuro (CLPT) United States $0.404B 0.00
Delcath Systems (DCTH) United States $0.370B 0.00
AngioDynamics (ANGO) United States $0.351B 0.00
CVRx (CVRX) United States $0.331B 0.00
NeuroPace (NPCE) United States $0.327B 0.00
Inogen (INGN) United States $0.227B 0.00
Alpha Tau Medical (DRTS) Israel $0.215B 0.00
Accuray (ARAY) United States $0.210B 0.00
Sight Sciences (SGHT) United States $0.203B 0.00
KORU Medical Systems (KRMD) United States $0.187B 0.00
Nevro (NVRO) United States $0.163B 0.00
Atossa Genetics (ATOS) United States $0.157B 0.00
Sensus Healthcare (SRTS) United States $0.143B 15.26
Spectral Diagnostics (EDTXF) Canada $0.105B 0.00
WORK Medical Technology Group (WOK) China $0.094B 0.00
LENSAR (LNSR) United States $0.090B 0.00
Vicarious Surgical (RBOT) United States $0.089B 0.00
Monogram Orthopaedics (MGRM) United States $0.084B 0.00
EDAP TMS S.A (EDAP) France $0.084B 0.00
908 Devices (MASS) United States $0.083B 0.00
InspireMD (NSPR) Israel $0.082B 0.00
Hyperfine (HYPR) United States $0.073B 0.00
Covalon Technologies (CVALF) Canada $0.071B 0.00
EnVVeno Medical (NVNO) United States $0.053B 0.00
Lucid Diagnostics (LUCD) United States $0.048B 0.00
Rapid Micro Biosystems (RPID) United States $0.045B 0.00
Envoy Medical (COCH) United States $0.044B 0.00
Spectral AI (MDAI) United States $0.038B 0.00
Accelerate Diagnostics (AXDX) United States $0.038B 0.00
Neuronetics (STIM) United States $0.035B 0.00
Adagio Medical Holdings (ADGM) United States $0.034B 0.00
Precision Optics (POCI) United States $0.032B 0.00
NexGel (NXGL) United States $0.025B 0.00
DarioHealth (DRIO) United States $0.023B 0.00
Biosig Technologies (BSGM) United States $0.019B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.015B 0.00
Aspira Women's Health (AWH) United States $0.012B 0.00
Baird Medical Investment Holdings (BDMD) $0.012B 0.00
T2 Biosystems (TTOO) United States $0.011B 0.00
QT Imaging Holdings (QTI) United States $0.011B 0.00
PAVmed (PAVM) United States $0.009B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00